Lithobid is a prescription medication that contains lithium carbonate as its active ingredient. It is administered in the form of a 300 mg pill and belongs to the mental health therapeutic class. In Hong Kong, Lithobid is regulated by the Pharmacy and Poisons Ordinance and is available only with a doctor's prescription.
Lithium carbonate stabilises mood by influencing several neurobiological pathways:
These actions collectively help control manic episodes and prevent depressive relapses in bipolar disorder.
Lithobid is approved by the Hong Kong Department of Health for the following indications:
Lithium carbonate is considered a first-line option for these conditions because of its proven efficacy in reducing the frequency and severity of mood episodes.
Evidence from peer-reviewed studies supports occasional off-label use of lithium carbonate for:
Off-label use requires medical supervision and individualized risk assessment.
Patients should inform their healthcare provider of all medications, supplements, and herbs before starting Lithobid.
Exact dosing must be individualized by a qualified healthcare provider.
This article provides educational information about Lithobid and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Lithobid tablets are permitted in both carry-on and checked luggage. Keep them in their original labeled container and carry a copy of the prescription or a doctor's note to avoid delays at security checkpoints.
Lithium may cause mild tremor or drowsiness in some individuals. If you notice any impairment in coordination or alertness, refrain from driving until the effect subsides and discuss the issue with your prescriber.
Lithobid 300 mg tablets are typically round, white to off-white, and bear the imprint “LITHOBID 300”. Appearance can vary slightly by manufacturer, so verify the imprint and packaging against the pharmacy label.
Lithobid is listed on the Hospital Authority’s formulary and may be subsidised for eligible patients. Eligibility depends on clinical indication and prescribing physician’s assessment.
Both lithium and valproate are effective for bipolar disorder, but lithium has the most robust evidence for reducing suicide risk. Valproate may be preferred in patients with renal impairment, while lithium requires regular monitoring of kidney and thyroid function.
Most antihistamines do not interact with lithium, but always inform your healthcare provider of any new OTC medication to confirm safety.
Take the missed tablet as soon as you remember, unless it is already close to the time of your next scheduled dose. Do not double the dose; maintaining a regular schedule is more important than compensating for a single missed tablet.
Lithobid is a brand name for lithium carbonate. Generic lithium carbonate tablets of the same strength (300 mg) are also available and are therapeutically equivalent.
Lithobid tablets retain potency for at least 24 months when stored in their original container, kept at room temperature, and protected from moisture. Check the expiration date on the packaging.
Brand-name Lithobid may be priced higher than generic lithium carbonate due to branding and distribution factors. Exact prices vary across pharmacies and are subject to government subsidies for eligible patients.
